You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
榮昌生物(688331.SH):完成發行H股

格隆匯5月29日丨榮昌生物(688331.SH)公佈,董事會欣然宣佈,配售協議中規定的所有先決條件均已達成(包括取得上市委員會就配售股份上市及買賣的批準),且配售事項已於2025年5月29日落實完成(簡稱“配售完成”)。本公司已於2025年5月29日按配售價每股配售股份42.44港元的價格,向不少於六名承配人(彼等及其最終實益擁有人爲獨立於本公司、本公司關連人士、本公司或其任何附屬公司的董事、監事、最高行政人員或主要股東或彼等其各自的聯繫人並概無關連的第三方)成功配發及發行合共19,000,000股新H股,佔經配發及發行配售股份擴大後的已發行H股總數約9.11%,以及已發行股份總數約3.37%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account